| Literature DB >> 28382594 |
Lifei Shao1,2, Shuping Yu3,4, Wei Ji1,2, Haizhen Li2,5, Yilu Gao6.
Abstract
Over the past decades, cell apoptosis has been significantly reputed as an accidental, redundant and alternative manner of cell demise which partakes in homeostasis in the development of extensive diseases. Nevertheless, necroptosis, another novel manner of cell death through a caspase-independent way, especially in neurodegenerative diseases remains ambiguous. The cognition of this form of cell demise is helpful to understand other forms of morphological resemblance of necrosis. Additionally, the concrete signal mechanism in the regulation of necroptosis is beneficial to the diagnosis and treatment of neurodegenerative diseases. Recent studies have demonstrated that necroptotic inhibitor, 24(S)-Hydroxycholesterol and partial specific histone deacetylase inhibitors could alleviate pathogenetic conditions of neurodegenerative diseases via necroptosis pathway. In this review, we summarize recent researches about mechanisms and modulation of necroptotic signaling pathways and probe into the role of programmed necroptotic cell demise in neurodegenerative diseases such as Parkinson's disease, Multiple sclerosis, Amyotrophic lateral sclerosis.Entities:
Keywords: Necroptosis; Neurodegenerative diseases; RIPK1; RIPK3; TNF
Mesh:
Year: 2017 PMID: 28382594 DOI: 10.1007/s11064-017-2249-1
Source DB: PubMed Journal: Neurochem Res ISSN: 0364-3190 Impact factor: 3.996